Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target

Suji Han; Hyemi Shin; Jin-Ku Lee; Zhaoqi Liu; Raul Rabadan; Jeongwu Lee; Jihye Shin; Cheolju Lee; Heekyoung Yang; Donggeon Kim; Sung Heon Kim; Jooyeon Kim; Jeong-Woo Oh; Doo-Sik Kong; Jung-Il Lee; Ho Jun Seol; Jung Won Choi; Hyun Ju Kang; Do-Hyun Nam

首页> 外文期刊>Experimental & molecular medicine. >Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target

【24h】

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target

机译：校正：患者衍生的GBM Tumorsbhers的秘密分析将米隆鉴定为有效的治疗靶标

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

After online publication of this article, the authors noticed an error in the Acknowledgments section.

机译：在本文的在线发布后，作者注意到“确认”部分中的错误。

著录项

来源
《Experimental & molecular medicine.》 |2020年第11期|共1页
作者
Suji Han; Hyemi Shin; Jin-Ku Lee; Zhaoqi Liu; Raul Rabadan; Jeongwu Lee; Jihye Shin; Cheolju Lee; Heekyoung Yang; Donggeon Kim; Sung Heon Kim; Jooyeon Kim; Jeong-Woo Oh; Doo-Sik Kong; Jung-Il Lee; Ho Jun Seol; Jung Won Choi; Hyun Ju Kang; Do-Hyun Nam;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类分子生物学;
关键词

相似文献

外文文献
中文文献
专利

1. Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target [J] . Peter J. Cook, Rozario Thomas, Ram Kannan, Nature Communications . 2018,第1期

机译：作者更正：体细胞染色体工程鉴定BCAN-NTRK1为有效的神经胶质瘤驱动物和治疗靶标
2. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target [J] . RasanenK., SriswasdiS., ValigaA., Molecular & cellular proteomics: MCP . 2013,第12期

机译：头颈部鳞状细胞癌上皮和间充质亚群的比较分泌组分析确定S100A4为潜在的治疗靶标
3. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target [J] . RasanenK., SriswasdiS., ValigaA., Molecular & cellular proteomics: MCP . 2013,第12期

机译：头颈部鳞状细胞癌上皮和间充质亚群的比较分泌组分析确定S100A4为潜在的治疗靶标
4. Keynote: LIPIDOMICS ANALYSIS OF CELLS AND TISSUES IDENTIFIES THERAPEUTIC TARGETS [C] . Michael Wakelam, An Nguyen, Qifeng Zhang, International Mass Spectrometry Conference . 2018

机译：Keynote：细胞和组织的脂质族分析鉴定治疗靶标
5. P27 as a molecular target for cancer therapeutics: Discovering small molecule inhibitors of p27 proteolysis and structure-activity relationship and mechanistic studies of largazole, a potent inhibitor of histone deacetylase . [D] . Ungermannova, Dana. 2010

机译：P27作为癌症治疗的分子靶标：发现p27蛋白水解和结构活性关系的小分子抑制剂以及组蛋白脱乙酰基酶的有效抑制剂largazole的机理研究。
6. Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target [O] . Suji Han, Hyemi Shin, Jin-Ku Lee, 2019

机译：对源自患者的GBM肿瘤球体的Secretome分析表明中期因子是有效的治疗靶标
7. Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target [O] . Suji Han, Hyemi Shin, Jin-Ku Lee, 2020

机译：校正：患者衍生的GBM肿瘤患者的克己续鉴定米西尼作为有效的治疗靶标

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅